Trials / Completed
CompletedNCT03512795
Optimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant Mutations
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The analysis of HIV resistance to antiretrovirals (Sanger sequencing on RNA) is difficult when the viral load is undetectable or during therapeutic breaks. In these situations, the ultra-deep sequencing (UDS) can be done on proviral DNA in order to improve characterization of archived resistant variants with may reflect past virological failures. This study is a cross-sectional study which will require only one additional tube which can be taken during a routine check-up as part of the usual follow-up of the individuals included.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood samples | An additional blood tube will be taken during the patient's follow-up blood collection. |
Timeline
- Start date
- 2018-08-08
- Primary completion
- 2020-03-05
- Completion
- 2020-03-05
- First posted
- 2018-05-01
- Last updated
- 2024-02-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03512795. Inclusion in this directory is not an endorsement.